Alpha Tau Medical Ltd. (DRTS)
NASDAQ: DRTS · Real-Time Price · USD
13.38
+0.02 (0.15%)
At close: Nov 13, 2026, 4:00 PM EST
13.35
-0.03 (-0.22%)
After-hours: Nov 13, 2026, 7:47 PM EST

Alpha Tau Medical Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
1,235422217209219338
Market Cap Growth
265.92%94.21%3.92%-4.71%-34.99%-
Enterprise Value
1,150363165128112351
Last Close Price
13.384.953.103.013.189.82

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
28.045.473.472.482.088.93
P/TBV Ratio
28.045.473.472.482.08-

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.340.180.200.160.05-
Net Debt / Equity Ratio
-1.94-0.77-0.75-0.81-0.94-0.83
Net Debt / EBITDA Ratio
1.751.451.351.983.192.41
Net Debt / FCF Ratio
5.311.812.142.814.012.13
Quick Ratio
10.456.996.9111.5724.177.22
Current Ratio
11.097.457.4012.0824.557.41
Return on Equity (ROE)
-141.68%-61.00%-43.16%-30.67%-47.07%-61.48%
Return on Assets (ROA)
-25.71%-27.55%-23.27%-19.60%-24.74%-18.11%
Return on Capital Employed (ROCE)
-40.50%-44.40%-46.50%-35.60%-27.70%-36.50%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-7.86%-10.10%-14.61%-13.94%-15.38%-8.08%
FCF Yield
-1.30%-7.76%-10.13%-11.65%-11.29%-4.37%
Buyback Yield / Dilution
-20.98%-15.24%-0.79%-9.20%-56.74%-0.65%
SEC Filings: 10-K · 10-Q